ExodusPoint Capital Management’s Whitehawk Therapeutics WHWK Stock Holding History

ExodusPoint Capital Management’s Portfolio WHWK Stock Details WHWK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-307,759	Closed	-$1.49M	–	2146
2023 Q3	$1.49M	Buy	307,759 +171,248	+125%	+$995K	0.01%	798
2023 Q2	$934K	Buy	136,511 +34,676	+34%	+$270K	0.01%	1130
2023 Q1	$737K	Buy	101,835 +26,510	+35%	+$283K	0.01%	1237
2022 Q4	$966K	Buy	75,325 +17,795	+31%	+$232K	0.01%	962
2022 Q3	$813K	Buy	57,530 +16,364	+40%	+$215K	0.01%	1190
2022 Q2	$507K	Sell	41,166 -2,706	-6%	-$40.2K	0.01%	1342
2022 Q1	$745K	Buy	+43,872	New	+$841K	0.01%	1319
2021 Q3	–	Sell	-1,001	Closed	-$25K	–	2749
2021 Q2	$25K	Buy	+1,001	New	+$22.9K	﹤0.01%	2253

Other funds holding WHWK

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

AIM

Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ExodusPoint Capital Management's WHWK Position: Q4 2023 in Review

ExodusPoint Capital Management sold out of Whitehawk Therapeutics (WHWK) in Q4 2023, closing a stake of 307,759 shares — an estimated $1.49M sold.

ExodusPoint Capital Management first reported a position in WHWK in Q2 2021 and held it in 8 quarters. The position peaked at $1.49M in Q3 2023. 65 funds tracked by Wall St. Rank hold WHWK as of Q4 2023.

ExodusPoint Capital Management reported no remaining Whitehawk Therapeutics position as of Q4 2023 after selling out during the quarter.
ExodusPoint Capital Management sold 307,759 Whitehawk Therapeutics shares in Q4 2023, an estimated $1.49M.
ExodusPoint Capital Management first reported a position in Whitehawk Therapeutics in Q2 2021 and held it in 8 quarters.
ExodusPoint Capital Management's Whitehawk Therapeutics position peaked at $1.49M in Q3 2023.
65 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q4 2023.

Based on ExodusPoint Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.